Rasagiline
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Rasagiline Product Information
Rasagiline is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Rasagiline. The product is supplied by Clearsynth under CAT No. CS-O-11733.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Rasagiline
CAS No.
136236-51-6
CAT No.
CS-O-11733
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C12H13N
Molecular Weight
171.2
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Rasagiline is supplied with detailed characterization data compliant with regulatory guideline. Rasagiline can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Rasagiline.
Overview
"Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease."
Synonyms
Rasagiline
Application Notes
"Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.